Synergistic Antitumor Activity of Alnuctamab (ALNUC; BMS-986349; CC-93269), a BCMA 2+1 T Cell Engager (TCE), and Celmod Agents in Multiple Myeloma (MM) Preclinical Models
Bruno Paiva, Bonny Gaffney, Kelven Burnett, Paola Castiglioni, Michael Angelo, Daniel W. Pierce, Isaac W. Boss
Topics & Concepts
Multiple myelomaCancer researchMedicinePharmacologyChemistryInternal medicineMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsQuinazolinone synthesis and applications